Literature DB >> 30166199

Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000-2017.

Saeko Morino1, Keiko Tanaka-Taya1, Hiroshi Satoh1, Satoru Arai1, Takuri Takahashi1, Tomimasa Sunagawa1, Kazunori Oishi2.   

Abstract

Routine childhood immunization using two doses of the varicella vaccine was introduced in Japan in October 2014. In this study, we analyzed the data extracted from national varicella surveillance, including pediatric sentinel surveillance from 2000 to 2017 and hospitalized varicella surveillance from the 38th week of 2014 to the 37th week of 2017. Compared with the 2000-2011 baseline data, the number of varicella cases per sentinel decreased substantially by 76.6% overall and by 88.2% among children aged 1-4 years in 2017. Of 997 hospitalized patients, we found a decreasing trend in the number of cases among children aged <5 years. We also found a decreasing trend in the number of cases with complications among children aged 1-4 years. Data on the self-reported transmission sites in 35.5% (354/997) of the hospitalized varicella patients showed that transmission of varicella zoster virus (VZV) occurred frequently in household, at school for young children, in the workplace for adults, and at hospital for all age groups. Data from 29.0% (289/997) of the hospitalized patients with a self-reported source of infection showed that transmission of VZV occurred from a patient with herpes zoster (HZ) in 30.4% (88/289) of cases. Our data demonstrate a substantial decrease in the number of varicella cases in young children following introduction of routine childhood vaccination program with two-dose varicella vaccination in Japan. These data highlight the unique aspects of transmission sites across age groups and the important role of HZ cases in disease circulation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Herpes zoster; Hospitalized surveillance; Routine immunization; Sentinel surveillance; Varicella

Mesh:

Substances:

Year:  2018        PMID: 30166199     DOI: 10.1016/j.vaccine.2018.08.048

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Routine varicella vaccination program and hospitalization for herpes zoster in Japan.

Authors:  Yasutaka Kuniyoshi; Haruka Tokutake; Natsuki Takahashi; Azusa Kamura; Sumie Yasuda; Makoto Tashiro
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

Review 2.  Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives.

Authors:  Wei Wang; Dequan Pan; Tong Cheng; Hua Zhu
Journal:  Viruses       Date:  2022-04-20       Impact factor: 5.818

3.  A case of maternal varicella: Expected role of primary care physicians in confirming immune status for varicella in women at childbearing age.

Authors:  Yuji Nishihara; Ryota Hase
Journal:  J Gen Fam Med       Date:  2019-12-13

4.  Development of a skin- and neuro-attenuated live vaccine for varicella.

Authors:  Wei Wang; Dequan Pan; Wenkun Fu; Xiangzhong Ye; Jinle Han; Lianwei Yang; Jizong Jia; Jian Liu; Rui Zhu; Yali Zhang; Che Liu; Jianghui Ye; Anca Selariu; Yuqiong Que; Qinjian Zhao; Ting Wu; Yimin Li; Jun Zhang; Tong Cheng; Hua Zhu; Ningshao Xia
Journal:  Nat Commun       Date:  2022-02-11       Impact factor: 17.694

5.  Varicella pneumonia in an immunocompetent, unvaccinated man: A case report.

Authors:  Nobumasa Okumura; Masahiro Ishikane; Shuetsu Fukushi; Souichi Yamada; Wataru Ochi; Noriko Iwamoto; Kei Yamamoto; Mugen Ujiie; Norio Ohmagari
Journal:  IJID Reg       Date:  2021-12-06

Review 6.  Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles.

Authors:  Naruhito Otani; Masayuki Shima; Takuma Yamamoto; Toshiomi Okuno
Journal:  Viruses       Date:  2022-03-12       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.